Welcome to LookChem.com Sign In|Join Free

CAS

  • or

281191-65-9

Post Buying Request

281191-65-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

281191-65-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 281191-65-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,1,1,9 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 281191-65:
(8*2)+(7*8)+(6*1)+(5*1)+(4*9)+(3*1)+(2*6)+(1*5)=139
139 % 10 = 9
So 281191-65-9 is a valid CAS Registry Number.

281191-65-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-hydroxy-3-iodo-5-methoxybenzoate

1.2 Other means of identification

Product number -
Other names Benzoic acid,4-hydroxy-3-iodo-5-methoxy-,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:281191-65-9 SDS

281191-65-9Relevant articles and documents

Efficient and sustainable laccase-catalyzed iodination of: P -substituted phenols using KI as iodine source and aerial O2 as oxidant

Sdahl, Mark,Conrad, Jürgen,Braunberger, Christina,Beifuss, Uwe

, p. 19549 - 19559 (2019/07/05)

The laccase-catalyzed iodination of p-hydroxyarylcarbonyl- and p-hydroxyarylcarboxylic acid derivatives using KI as iodine source and aerial oxygen as the oxidant delivers the corresponding iodophenols in a highly efficient and sustainable manner with yields up to 93% on a preparative scale under mild reaction conditions.

ANTIVIRAL COMPOUNDS

-

Paragraph 0630; 0631, (2016/09/26)

Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus v

Ester derivatives and medicinal use thereof

-

Page/Page column 45, (2010/11/08)

The present invention relates to an ester represented by the formula [1]: or its pharmaceutically acceptable salt, or use of the same. The compound represented by the formula [1] or its pharmaceutically acceptable salt is useful as an agent for the treatment or prophylaxis of hyperlipidemia or the like, since it disappears very rapidly in the living body and has an excellent MTP inhibitory activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 281191-65-9